Resumption of intracellular Ca2+ cycling as a novel therapeutic strategy for heart failure
Resumption of intracellular Ca2+ cycling as a novel therapeutic strategy for heart failure
批准号:
17590717
负责人:
SATOH Hiroshi
金额:
$1.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Altered cellular Ca^<2+> handling plays a key role in the pathophysiology of heart failure. A typical aspect of failing heart cells is a decrease in the ability to load Ca^<2+> in the sarcoplasmic reticulum (SR), which results in a decreased amplitude and a slowed decay rate of Ca^<2+> transients, and an increased diastolic [Ca^<2+>]_i. This unloaded SR Ca^<2+> could be ascribed to a decrease in Ca^<2+> re-uptake by SR Ca^<2+> ATPase (SERCA), an increase in Ca^<2+> extrusion by the over-expression of Na^+/Ca^<2+> exchange (NCX), and an increase in the SR Ca^<2+> leak by the dissociation of FK506-binding proteins from the SR Ca^<2+> release channel. Many inotropic agents including digitalis and β-receptor agonists have failed to improve long-term prognosis of heart failure in clinical studies. For the SR Ca2+ uptake, drugs that enhance SR Ca^<2+> uptake in a cAMP-independent manner, including protein phosphatase inhibitors and MCC-135, are candidates. In 2005, we initially investigated … More the effect of a direct SERCA activator, MCC-135, on the profiles of Ca^<2+> transients and cell contraction in isolated rat cardiomyocytes. Unfortunately, we could not obtain significant inotropic effects of MCC-135. In 2006, we studied the effect of I-1, a specific protein phosphatase-1 inhibitor on cellular Ca^<2+> handling in permeabilized rat ventricular myocytes. As a result, I-1 increased SR Ca^<2+> content without altering SR Ca^<2+> release manner. For NCX, we clarified the inhibition modality of novel specific inhibitors of NCX, SEA0400 and SN-6 using patch clamp technique in guinea pig ventricular myocytes. SN-6 inhibited Ca^<2+> influx mode of NCX selectively, and SEA0400 equally blocked both Ca^<2+> efflux and influx mode. SEA0400 also protected rat perfused hearts against ischemia/reperfusion injury by preserving high energy metabolism. Despite limitations for clinical use, the combination of these agents may restore cellular Ca^<2+> cycling and improve cardiac function with less toxicity. Less
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Evaluation of right and left ventricular function by quantitative blood-pool SPECT (QBS) : Comparison with conventional methods and quantitative gated SPECT (QGS).
通过定量血池 SPECT (QBS) 评估右心室和左心室功能:与常规方法和定量门控 SPECT (QGS) 的比较。
DOI:
--
发表时间:
2006
期刊:
Annals of Nuclear Medicine 20
影响因子:
--
作者:
[Chimushi M, Izumi D, Komura S, Ahara S, Satoh A, Furushima H, Washizuka T, Aizawa Y, Keiichi Odagiri]
通讯作者:
Keiichi Odagiri
Different actions of cardioprotective agents on mitochondrial Ca2+ regulation in a Ca2+ paradox-induced Ca2+ overload.
在 Ca2 悖论诱导的 Ca2 超载中,心脏保护剂对线粒体 Ca2 调节的不同作用。
DOI:
--
发表时间:
2005
期刊:
Circulation Journal
影响因子:
3.3
作者:
[Masaki Matsunaga, M. Saotome, H. Satoh, H. Katoh, H. Terada, H. Hayashi]
通讯作者:
H. Hayashi
DOI:
10.1016/j.cardiores.2005.11.023
发表时间:
2006-03-01
期刊:
CARDIOVASCULAR RESEARCH
影响因子:
10.8
作者:
[Nakano, T, Watanabe, H, Hayashi, H]
通讯作者:
Hayashi, H
DOI:
10.1253/circj.70.1407
发表时间:
2006-11
期刊:
Circulation journal : official journal of the Japanese Circulation Society
影响因子:
--
作者:
[K. Yamazaki;H. Terada;H. Satoh;K. Naito;A. Takeshita;A. Uehara;H. Katoh;K. Ohnishi;H. Hayashi]
通讯作者:
K. Yamazaki;H. Terada;H. Satoh;K. Naito;A. Takeshita;A. Uehara;H. Katoh;K. Ohnishi;H. Hayashi
A selective inhibitor of Na+/Ca2+ exchanger, SEA400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
SEA400 是 Na /Ca2 交换器的选择性抑制剂,可保护心脏功能和高能磷酸盐免受缺血/再灌注损伤。
DOI:
--
发表时间:
2006
期刊:
Journal of Cardiovascular Pharmacology. 47
影响因子:
--
作者:
[Buensuceso CS, Obergfell A, Soriani A, Eto K, Miosses WB, Arias-Salgado EG, Kawakami T, Shattil SJ, Niu Chenfung et al.]
通讯作者:
Niu Chenfung et al.
共 11 条
Study for intracellular direct effects of renin-angiotensin system in diabetic hearts
-
批准号:22590776
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:SATOH Hiroshi
-
依托单位:
Mother-to-child kinetics and exposure assessment model for co-exposure to methylmercury and POPs during perinatal periods
-
批准号:21249039
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$27.96万
-
财政年份:2009
-
负责人:SATOH Hiroshi
-
依托单位:
Does selenium deficiency deteriorate the effects of methylmercury exposure?
-
批准号:18209022
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.12万
-
财政年份:2006
-
负责人:SATOH Hiroshi
-
依托单位:
Study for detection of intracellular sodium transients and their pathophysiological roles in myocytes
-
批准号:15590733
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2003
-
负责人:SATOH Hiroshi
-
依托单位:
Neurobehavioral effects of low-dose long-term methylmercury exposures in mice
-
批准号:13307014
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$34.03万
-
财政年份:2001
-
负责人:SATOH Hiroshi
-
依托单位:
Study for the Abnormality of Intracellular Ca^<2+> Regulation in Failing Hearts
-
批准号:13670701
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2001
-
负责人:SATOH Hiroshi
-
依托单位:
An occupational health approach to prevent the lifestyle-related diseases based on genetic information.
-
批准号:13557029
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.13万
-
财政年份:2001
-
负责人:SATOH Hiroshi
-
依托单位:
Study for the Abnormality of Intracellular Calcium Regulation in Myocardial Ischemia
-
批准号:11670670
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:SATOH Hiroshi
-
依托单位:
Genotoxicity of airborne particles from the urban area in Sapporo : Evaluation of the particulate samples collected over 22 year by bioassays
-
批准号:09557033
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:1997
-
负责人:SATOH Hiroshi
-
依托单位:
Microdialytic and behavioral pharmacological evaluation of mice offspring prenatally exposed to low-level methylmercury.
-
批准号:08457124
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.12万
-
财政年份:1996
-
负责人:SATOH Hiroshi
-
依托单位:
Analysis of malignant biology and gene disorder in gastric MALT lymphomas
-
批准号:07671404
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.19万
-
财政年份:1995
-
负责人:SATOH Hiroshi
-
依托单位:
Studies on the element disorders in the pathogenesis of neurodegenerative diseases and prevention of these diseases.
-
批准号:06454233
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.58万
-
财政年份:1994
-
负责人:SATOH Hiroshi
-
依托单位:
A STUDY ON ESTIMATION OF MERCURY DEPOSIT IN EX-MINERS WHO FORMERLY EMPLOYED IN A MERCURY MINE
-
批准号:02454197
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.78万
-
财政年份:1990
-
负责人:SATOH Hiroshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张明明
-
依托单位:
钙信号负向调节因子IRBIT抑制肝癌细胞恶性生物学行为的分子机制研究
-
批准号:31960151
-
项目类别:地区科学基金项目
-
资助金额:40.0万元
-
批准年份:2019
-
负责人:徐靖宇
-
依托单位:
基于钙信号特征机制的肿瘤转移调控研究
-
批准号:31970729
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:魏朝亮
-
依托单位:
一种拟南芥IP3结合蛋白作用机制及功能研究
-
批准号:31970723
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:韩生成
-
依托单位:
miR-30调控Calcium/Calcineurin通路在慢性肾脏病心肌保护中的作用
-
批准号:81670699
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:郑春霞
-
依托单位:
钙磷基纳米粒子的分布降解及其成骨系细胞响应机制研究
-
批准号:81171682
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:陈大福
-
依托单位:
TRPCs,STIMs及Orais在钙敏感受体介导钙内流及一氧化氮生成中作用和机制研究
-
批准号:31160239
-
项目类别:地区科学基金项目
-
资助金额:53.47万元
-
批准年份:2011
-
负责人:何芳
-
依托单位:
缺氧状况下ATP对血管的调节作用
-
批准号:81041100
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:顾雨春
-
依托单位:
水稻OsCAS(Calcium-sensing Receptor)基因的功能分析
-
批准号:30900771
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:赵昕
-
依托单位:
小胶质细胞转核P2X7受体介导的生物学效应的研究
-
批准号:30970918
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2009
-
负责人:向正华
-
依托单位: